![]() Vertical constellation from Calder ... |
|
Pharmacokinetics and Pharmacodynamics (PK/PD) have now become essential tools for determining the appropriate use of currently available anti-infective agents as well as for accelerating the development of new drugs. While this is now more and more recognized by Academia, Industry and Regulatory Agencies (see the ISAP / FDA and ISAP / EMEA workshops held in 1999), there is still a lack of training into these disciplines. Accordingly, ISAP has endeavoured to launch educational activities in this context. The aim is to train people professionally involved in development or in the use of antiinfective drugs in the basic and applied aspects of pharmacokinetics and pharmacodynamics, showing how these sciences have emerged over the last 10 years and how their influence has grown.
Since
1999, ISAP has
already organized several educational workshops in association with
ECCMID
and ICAAC [see "Past
Educational Activities"]. Following specific demands, the
educational workshop held with ICAAC since this year have been
organized in three parts (half a
day each) dealing with
Objectives:
Intended
Audience: Medical microbiologists, infectious diseases
specialists, pharmacologists, and others interested
Level:
Beginning
Prerequisites:
None
| Preclinical Pharmacokinetics and Pharmacodynamics of Anti-infective Agents | ||
| Introduction to PK/PD | H. Derendorf,
PhD Department of Pharmaceutics, University of Florida, Gainsville, FL |
|
| PK/PD indices | J. Mouton,
MD, PhD Canisius Wilhelmina Hospital, Nijmegen, The Netherlands |
|
| Protein binding, tissue distribution | U. Theuretzbacher Antibiotic Center, University of Vienna, Vienna, Austria |
|
| In vitro models | I. Odenholt, MD Departement of Infectious Diseases, Malmö University Hospital, Malmö, Sweden |
|
| Animal models | W.A. Craig, Division of Infectious Diseases, University of Wisconsin, Madison, WI |
|
| In vitro resistance | O. Cars, Division of Infectious Diseases, University Hospital, Uppsala, Sweden |
|
| Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-infective Agents | ||
| Clinical applications of PK/PD | Paul M. Tulkens,
MD,PhD Department of Pharmaceutics, Catholic University of Louvain, Brussels, Belgium |
|
| Drug exposure at infection site | M. Mueller, MD Department of Clinical Pharmacology, Vienna University Medical School, Vienna, Austria. |
|
| |
PK/PD of antivirals | G.L. Drusano, MD Division of Clinical Pharmacology, Albany Medical College, Alabany, NY |
| PK/PD of antifungals | D.R. Andes, MD Department of Medicine, University of Wisconsin Medical School, Madison, WI |
|
| |
Clinical resistance | O. Cars, MD, MPH Division of Infectious Diseases, University Hospital, Uppsala, Sweden |
| Clinical dose optimization | J. Mouton, MD, PhD Canisius Wilhelmina Hospital, Nijmegen, The Netherland |
|
| PK/PD Modeling of Anti-infective Agents | ||
| In vitro MIC based PK/PD | A.P. MacGowan,
MD,PhD Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust & University of Bristol Department of Medical Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UK |
|
| |
PK/PD in animals | W.A. Craig, Division of Infectious Diseases, University of Wisconsin, Madison, WI |
| |
PK/PD based on kill curves | H.
Derendorf, PhD Department of Pharmaceutics, University of Florida, Gainsville, FL |
| Population PK/PD | A.A. Vinks, PhD Division of Pharmacology Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH |
|
| |
Modeling of anti-infective activity | A. Forrest, PhD Clinical Pharmacokinetics Laboratory (CPL), Uiversity of New York at Buffalo, Buffalo, NY |
| Monte Carlo Simulations | G.L. Drusano, MD Division of Clinical Pharmacology, Albany Medical College, Alabany, NY |
|
This
will be handled by
the
American Society for Microbiology (ASM). ASM is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to
sponsor
continuing medical education for physicians. ASM has designated
full-day
workshops for 7 hours of category 1 credit towards the American Medical
Association Physician's Recognition Award. Diplomates of the American
Board
of Medical Microbiology, Diplomates of the American Board of Medical
Laboratory
Immunology, and Registrants of the National Registry of Microbiologists
may earn category 1 credit toward recertification. Each physician
should
claim only those hours of credit that he/she actually spent in the
educational
activity.
The
workshop will take
place
in Washington, DC, at the 44th Interscience Conference on
Antimicrobial
Agents and Chemotherapy (ICAAC). Room no. will be
posted
clearly at the entrance of the Convention Center.
Please,
refer to the ICAAC Web site (http://www.icaac.org)
site for all additional and "up to the last minute" details.
ISAP
will not be
responsible
for accomodation which must be taken care of individually by each
participant.
Attendants participating to the may wish to take
advantage
of the offerings made by the 44th
Interscience Conference on
Antimicrobial
Agents and Chemotherapy (ICAAC). Please,
refer to the ICAAC Web site (http://www.icaac.org)
site for all additional and "up to the last minute" details. See
also the "Useful links" section
hereunder.
Registration
is open to
all
ISAP members and to all professionals active or having
interest
in the pharmacokinetics and pharmacodynamics of antiinfective
agents.
Registration is
exclusively
through the 44th Interscience Conference on Antimicrobial Agents
and
Chemotherapy (ICAAC). Please,
refer to the ICAAC Web site (http://www.icaac.org)
site for registration.
Important:
As per ICAAC policy, attendance to workshops is limited (so as
to foster interactivity and real discussions). Registration to
workshops is made by ICAAC on a first-come first-served basis.
Our experience is that these PK/PD workshops fill up pretty quickly, so
that early registration is recommended. Please, do not contact
ISAP in this context.
![]() |
![]() |
pPractical and useful information on Washington
and the District of Columbia
|
p |
![]() |
![]() |
Accomodation and restaurants
|
d |
|
|
|
Last
update: February 7th, 2004
Back
to ISAP home page
Back
to ISAP home page